Carolyn M. Klinge
#164,187
Most Influential Person Now
Researcher
Carolyn M. Klinge's AcademicInfluence.com Rankings
Carolyn M. Klingebiology Degrees
Biology
#13203
World Rank
#16735
Historical Rank
Cell Biology
#728
World Rank
#743
Historical Rank
Molecular Biology
#2205
World Rank
#2239
Historical Rank
Neuroscience
#2271
World Rank
#2332
Historical Rank
Download Badge
Biology
Carolyn M. Klinge's Degrees
- PhD Biochemistry University of California, San Francisco
- Masters Molecular Biology Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Carolyn M. Klinge Influential?
(Suggest an Edit or Addition)Carolyn M. Klinge's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Estrogen receptor interaction with estrogen response elements. (2001) (1014)
- MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene (2008) (699)
- Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β. (2000) (511)
- Estrogen receptor interaction with co-activators and co-repressors☆ (2000) (501)
- Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells (2009) (365)
- Estrogenic control of mitochondrial function and biogenesis (2008) (285)
- Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. (2000) (256)
- Resveratrol and Estradiol Rapidly Activate MAPK Signaling through Estrogen Receptors α and β in Endothelial Cells* (2005) (255)
- Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. (2008) (225)
- Sequence Requirements for Estrogen Receptor Binding to Estrogen Response Elements* (1998) (216)
- miRNAs and estrogen action (2012) (182)
- Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors α and β by coactivators and corepressors (2004) (175)
- Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. (2005) (167)
- Resveratrol stimulates nitric oxide production by increasing estrogen receptor αa‐Src‐caveolin‐1 interaction and phosphorylation in human umbilical vein endothelial cells (2008) (163)
- Estrogen Regulation of MicroRNA Expression (2009) (135)
- The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements (1999) (127)
- The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1. (2000) (120)
- Chicken Ovalbumin Upstream Promoter-Transcription Factor Interacts with Estrogen Receptor, Binds to Estrogen Response Elements and Half-Sites, and Inhibits Estrogen-induced Gene Expression* (1997) (113)
- Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication (2018) (112)
- Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. (2010) (110)
- Novel mechanisms for DHEA action. (2016) (106)
- Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. (2004) (105)
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells (2013) (98)
- Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers. (2018) (96)
- miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets (2015) (95)
- Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor α 1 Supported by NIH R01 DK 53220 and a University of Louisville School of Medicine Research Grant to C.M.K. 1 (2001) (92)
- Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells (2006) (90)
- Estrogenic activity in white and red wine extracts. (2003) (90)
- Estrogenic control of mitochondrial function (2020) (85)
- Effects of multiple estrogen responsive elements, their spacing, and location on estrogen response of reporter genes. (1997) (81)
- Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro. (1997) (79)
- Estrogens regulate life and death in mitochondria (2017) (77)
- A Conceptual Framework for Mentoring in a Learning Organization (2015) (74)
- Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription (2010) (74)
- Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. (1992) (73)
- Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. (2011) (69)
- Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer (2012) (69)
- Roles for miRNAs in endocrine resistance in breast cancer. (2015) (67)
- Effect of nonpersistent pesticides on estrogen receptor, androgen receptor, and aryl hydrocarbon receptor (2014) (61)
- HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells (2019) (60)
- DHEA metabolites activate estrogen receptors alpha and beta (2013) (59)
- Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. (1995) (58)
- Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT). (2001) (56)
- Antiandrogenic activities of diesel exhaust particle extracts in PC3/AR human prostate carcinoma cells. (2003) (56)
- Activity and intracellular location of estrogen receptors α and β in human bronchial epithelial cells (2009) (55)
- Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells. (2010) (53)
- Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF) (1999) (51)
- Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner. (2004) (51)
- Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells. (2016) (50)
- Response element sequence modulates estrogen receptor alpha and beta affinity and activity. (2002) (50)
- Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. (2006) (49)
- Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. (2012) (49)
- Regulation of breast cancer metastasis signaling by miRNAs (2020) (48)
- Anacardic Acid Inhibits Estrogen Receptor α–DNA Binding and Reduces Target Gene Transcription and Breast Cancer Cell Proliferation (2010) (48)
- Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen. (2015) (48)
- Regulation of estrogenic and nuclear factor κB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells (2001) (48)
- Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells (2018) (45)
- Polyamine-mediated conformational perturbations in DNA alter the binding of estrogen receptor to poly(dG-m5dC).poly(dG-m5dC) and a plasmid containing the estrogen response element (1995) (45)
- Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells. (2013) (45)
- Estradiol downregulates miR-21 expression and miR-21 gene targets in MCF-7 breast cancer cells. (2009) (45)
- Dehydroepiandrosterone Research: Past, Current, and Future. (2018) (43)
- Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells* (2015) (43)
- Antiandrogenic activity of extracts of diesel exhaust particles emitted from diesel-engine truck under different engine loads and speeds. (2004) (42)
- Multiple roles of COUP-TFII in cancer initiation and progression. (2012) (42)
- Comparison of transcriptional synergy of estrogen receptors α and β from multiple tandem estrogen response elements (2000) (40)
- Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors (1996) (39)
- Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells. (2006) (38)
- Rapid effects of diesel exhaust particulate extracts on intracellular signaling in human endothelial cells. (2007) (37)
- Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA (1993) (36)
- Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells. (2017) (36)
- Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer (2017) (35)
- Repression of activated aryl hydrocarbon receptor-induced transcriptional activation by 5alpha-dihydrotestosterone in human prostate cancer LNCaP and human breast cancer T47D cells. (2009) (35)
- The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells (2017) (34)
- Identification and Characterization of Nucleolin as a COUP-TFII Coactivator of Retinoic Acid Receptor β Transcription in Breast Cancer Cells (2012) (34)
- Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity. (2007) (33)
- Regulation of cell cycle and cyclins by 16alpha-hydroxyestrone in MCF-7 breast cancer cells. (2001) (32)
- Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor β and AP‐1 recruitment to adjacent promoter binding sites (2011) (32)
- Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression (1999) (32)
- Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells. (2016) (31)
- Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA (1996) (31)
- Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro (1992) (30)
- Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis (2015) (30)
- Targeting the Intracellular MUC1 C-terminal Domain Inhibits Proliferation and Estrogen Receptor Transcriptional Activity in Lung Adenocarcinoma Cells (2011) (29)
- Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor (2014) (29)
- Rapid purification of the estrogen receptor by sequence-specific DNA affinity chromatography. (1989) (28)
- Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability. (1996) (27)
- Footprint analysis of estrogen receptor binding to adjacent estrogen response elements (1996) (27)
- Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements (1998) (27)
- Transcriptomic response of breast cancer cells to anacardic acid (2018) (26)
- hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in Vitro (1997) (24)
- Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements. (2000) (24)
- Biomimetic hydrogels with VEGF induce angiogenic processes in both hUVEC and hMEC. (2011) (24)
- Effect of estradiol and dihydrotestosterone on hypergravity-induced MAPK signaling and occludin expression in human umbilical vein endothelial cells (2006) (24)
- Mechanisms of Action of Dehydroepiandrosterone. (2018) (24)
- COUP-TFII inhibits NFkappaB activation in endocrine-resistant breast cancer cells (2014) (24)
- The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells. (2002) (23)
- Interaction of Tetrahydrocrysene Ketone with Estrogen Receptors α and β Indicates Conformational Differences in the Receptor Subtypes (2000) (23)
- A mathematical approach to predict the affinity of estrogen receptors α and β binding to DNA (2001) (23)
- What differentiates antiestrogen-liganded vs estradiol-liganded estrogen receptor action? (1992) (23)
- Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro. (1987) (22)
- Identifying sex differences arising from polychlorinated biphenyl exposures in toxicant-associated liver disease. (2019) (21)
- Estradiol and tamoxifen regulate NRF-1 and mitochondrial function in mouse mammary gland and uterus. (2013) (21)
- HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. (2021) (20)
- Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro (1996) (20)
- Knockout of human arylamine N‐acetyltransferase 1 (NAT1) in MDA‐MB‐231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity (2018) (19)
- Identification of structurally altered estrogen receptors in human breast cancer by site-directed monoclonal antibodies (1995) (19)
- β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression (2014) (19)
- A test of the hypothesis that a 60-Hz magnetic field affects ornithine decarboxylase activity in mouse L929 cells in vitro. (1995) (18)
- Polyamine biosynthesis inhibitors alter protein-protein interactions involving estrogen receptor in MCF-7 breast cancer cells. (1999) (18)
- Transcription profiling of estrogen target genes in young and old mouse uterus (2003) (17)
- Selectivity of antibodies to estrogen receptors α and β (ERα and ERβ) for detecting DNA-bound ERα and ERβ in vitro (2000) (16)
- A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements. (1990) (16)
- Antiestrogenic Activity of Extracts of Diesel Exhaust Particulate Matter in MCF-7 Human Breast Carcinoma Cells (2002) (16)
- MUC1/A and MUC1/B splice variants differentially regulate inflammatory cytokine expression. (2011) (16)
- Estrogen action: Receptors, transcripts, cell signaling, and non-coding RNAs in normal physiology and disease (2015) (16)
- A new luciferase reporter gene assay for the detection of androgenic and antiandrogenic effects based on a human prostate specific antigen promoter and PC3/AR human prostate cancer cells. (2004) (15)
- Estrogen Receptors α and β Exhibit Different Estradiol and Estrogen Response Element Binding in the Presence of Nonspecific DNA (2001) (15)
- GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells (2016) (15)
- Genome-wide miRNA response to anacardic acid in breast cancer cells (2017) (14)
- Identification of estrogen receptor beta expression in Chinese hamster ovary (CHO) cells and comparison of estrogen-responsive gene transcription in cells adapted to serum-free media (2003) (14)
- A mathematical approach to predict the affinity of estrogen receptors alpha and beta binding to DNA. (2001) (13)
- Estrogen response element binding induces alterations in estrogen receptor-alpha conformation as revealed by susceptibility to partial proteolysis. (2001) (13)
- Covalently grafted VEGF(165) in hydrogel models upregulates the cellular pathways associated with angiogenesis. (2011) (13)
- 17&bgr;-Estradiol attenuates cytokine-induced nitric oxide production in rat hepatocyte (2012) (13)
- Anacardic Acid, Salicylic Acid, and Oleic Acid Differentially Alter Cellular Bioenergetic Function in Breast Cancer Cells (2016) (13)
- High N-Acetyltransferase 1 Expression is Associated with Estrogen Receptor Expression in Breast Tumors, but is not Under Direct Regulation by Estradiol, 5α-androstane-3β, 17β-Diol, or Dihydrotestosterone in Breast Cancer Cells (2018) (12)
- 5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines. (2014) (12)
- Steroid Hormone Receptors and Signal Transduction Processes (2018) (11)
- Diesel exhaust particulate extracts inhibit transcription of nuclear respiratory factor-1 and cell viability in human umbilical vein endothelial cells (2012) (10)
- Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor β (2007) (10)
- Estrogen receptor alters the topology of plasmid DNA containing estrogen responsive elements. (1991) (10)
- Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells (2021) (10)
- VARIATION IN THE ANTIANDROGENIC ACTIVITY OF DIESEL EXHAUST PARTICULATES EMITTED UNDER DIFFERENT ENGINE LOADS (2004) (9)
- Inhibition of DNA polymerase α activity by proteins from rat liver (1985) (9)
- Estrogen receptor beta yield from baculovirus lytic infection is higher than from stably transformed Sf21 cells (2007) (9)
- Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells (2017) (9)
- Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver (2021) (9)
- Maximizing production of estrogen receptor beta with the baculovirus expression system. (2003) (8)
- Estrogen receptors alpha and beta exhibit different estradiol and estrogen response element binding in the presence of nonspecific DNA. (2001) (7)
- Regulation of cell cycle and cyclins by 16 -hydroxyestrone in MCF-7 breast cancer cells (2001) (7)
- Chapter Six – Anacardic Acid Biosynthesis and Bioactivity (2006) (7)
- Soy glyceollins regulate transcript abundance in the female mouse brain (2015) (7)
- Tender coconut water suppresses hepatic inflammation by activating AKT and JNK signaling pathways in an in vitro model of sepsis. (2020) (7)
- Serine synthesis influences tamoxifen response in ER+ human breast carcinoma. (2020) (6)
- Inhibition of non-small-cell lung cancer growth by combined fulvestrant and vandetanib. (2012) (6)
- Antiestrogen(4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status. (1989) (5)
- Circulating MicroRNAs, Polychlorinated Biphenyls, and Environmental Liver Disease in the Anniston Community Health Survey. (2022) (5)
- Selectivity of antibodies to estrogen receptors alpha and beta (ERalpha and ERbeta) for detecting DNA-bound ERalpha and ERbeta in vitro. (2000) (5)
- Part III: Steroid Hormone Receptors and Signal Transduction Processes (2016) (5)
- Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes. (2000) (4)
- Response element sequence modulates estrogen receptor (cid:1) and (cid:2) affinity and activity (2002) (4)
- Sphingosine-1-phosphate receptor-3 signaling upregulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells (2012) (4)
- Epidemics will always come (and go): The need to prepare for the next one, research on COVID-19, and the role of molecular and cellular endocrinology (2020) (3)
- Alteration of miR‐186 expression modifies inflammatory markers in normal epithelial and prostate cancer cell models (2017) (3)
- Multiomics analysis of the impact of polychlorinated biphenyls on environmental liver disease in a mouse model. (2022) (2)
- Bile Acid Binding Protein STARD5 Suppresses Doxorubicin‐mediated Apoptosis in H1792 Lung Adenocarcinoma Cells (2017) (2)
- Characterization of a cytosolic inhibitor of calf estrogen receptor binding to nuclei. (1987) (2)
- An endogenous protein inhibitor of DNA polymerase α in normal and neoplastic rat mammary tissues (1987) (2)
- Polychlorinated biphenyls alter hepatic m6A mRNA methylation in a mouse model of environmental liver disease. (2022) (2)
- Regulation of Gene Expression by β-Glucans (2017) (2)
- Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors. (1989) (2)
- Nuclease sensitivity of estradiol-charged estrogen receptor binding sites in nuclei isolated from normal and neoplastic rat mammary tissues. (1990) (1)
- Cadmium chloride and sodium arsenate, environmental estrogens in cigarette smoke, activate estrogen signaling pathways to induce proliferation in a human lung adenocarcinoma cell line (2007) (1)
- Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer (2012) (1)
- Keeping up with Genome Sequence and Expression (2014) (1)
- Novel and Alternative Bioinformatics Approaches to Understand miRNA-mRNA Interactome in Cancer Research (2012) (1)
- Diesel exhaust particulate extracts inhibit transcription of nuclear respiratory factor-1 and cell viability in human umbilical vein endothelial cells (2011) (1)
- Intranuclear dynamics of DNA polymerase alpha differs between the transplanted R3230AC mammary adenocarcinomas and the host mammary gland depending on lactation cycle. (1986) (1)
- Activation of membrane estrogen receptor: MAPK signaling by cadmium chloride and sodium arsenite in human lung adenocarcinoma cells (2016) (1)
- CARBON NANOTUBE MEMBRANE IN MICROCHANNEL FOR ELECTROPHORETIC SEPARATION OF PROTEINS (2008) (1)
- Investigation Of Phosphoserine Aminotransferase 1 And Its Role In Breast Cancer Progression (2018) (1)
- Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta. (2007) (1)
- Genetic and Epigenetic Mechanisms in Neural and Hormonal Controls over Female Reproductive Behaviors (2017) (1)
- Transcription Factors (2004) (1)
- Inhibition of DNA polymerase alpha activity by proteins from rat liver. (1985) (1)
- Abstract 3428: Tamoxifen differentially regulates miR-29b-1 and miR-29a depending on endocrine sensitivity in breast cancer (2017) (1)
- Abstract 4548: The role of GPR30/G-protein coupled estrogen receptor (GPER) in lung cancer development (2011) (0)
- Abstract 1435: Investigation of phosphoserine aminotransferase 1: Its role in breast cancer progression (2018) (0)
- Soy glyceollins regulate transcript abundance in the female mouse brain (2015) (0)
- alterations in MAPK activity cell barrier function after hypergravity-induced Estradiol and dihydrotestosterone regulate endothelial (2008) (0)
- The Steroid Hormone Receptors (2008) (0)
- SUN-009 N(6)-Methyladenosine Reader HNRNPA2B1 Regulates Tamoxifen-Sensitivity in Breast Cancer Cells (2019) (0)
- OR09-06 HNRNPA2B1 Mediates Endocrine-Sensitivity and Alters PSAT1 in Breast Cancer Cells (2020) (0)
- The Role of MUC1 Splice Variants in Cellular Inflammation (2010) (0)
- Development of Biomimetic Hydrogels for Guided Endothelial Cell Morphogenesis, Organization and Vessel Formation (2012) (0)
- Selective Estrogen Receptor Modulators as Therapeutic Agents in Breast Cancer Treatment (2004) (0)
- Epitranscriptomic Reader HNRNPA2B1 Confers Endocrine Resistance to Breast Cancer Cells (2021) (0)
- Author Correction: HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells (2021) (0)
- Abstract P6-04-30: COUP-TFII suppresses NFκB activation in endocrine-resistant breast cancer cells (2012) (0)
- Metabolic Analysis of Nucleosides/Bases in the Urine and Serum of Patients with Alcohol-Associated Liver Disease (2022) (0)
- Abstract 3734: Expression of serine synthetic enzymes alters the sensitivity of ER-positive breast cancer cells to tamoxifen (2020) (0)
- Transcriptomic response of breast cancer cells to anacardic acid (2018) (0)
- Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells (2018) (0)
- The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells (2017) (0)
- Erratum to “Transcription profiling of estrogen target genes in young and old mouse uterus” [Exp. Gerontol. 38 (2003) 1087–1099] (2004) (0)
- Decreased COUP‐TFII expression in tamoxifen resistant breast cancer (2006) (0)
- Mechanisms of Resveratrol and Estrogen in Cardioprotective Function (2018) (0)
- Gender‐specific differences in the expression and activity of estrogen receptors alpha and beta in lung adenocarcinoma cells (2006) (0)
- Regulation of breast cancer metastasis signaling by miRNAs (2020) (0)
- HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells (2019) (0)
- Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors (cid:1) and (cid:2) by coactivators and corepressors (2004) (0)
- Hormones and Cancer Reviewers (2011) (0)
- Role for miR-29b suppression in multiple myeloma (2018) (0)
- Abstract 1096: Loss of miR-200 family of microRNAs confers resistance to tamoxifen in human breast cancer cells (2012) (0)
- Suppression of miR‐186 Attenuates Cellular Invasion, pAKT and β‐catenin in Metastatic Prostate Cancer Cell Models (2018) (0)
- STARD5 expression and chemoresistance in lung adenocarcinoma cells (2011) (0)
- Carbon Nanotube Meshes for Separating Proteins Electrophoretically (2008) (0)
- Regulation of COUP‐TFII expression in Tamoxifen‐ sensitive and resistant breast cancer cells. (2006) (0)
- An endogenous protein inhibitor of DNA polymerase alpha in normal and neoplastic rat mammary tissues. (1987) (0)
- Abstract 2682: Targeting phosphoglycerate dehydrogenase (PHGDH) in combination with tamoxifen reduces hormone receptor positive breast cancer growth in vivo (2023) (0)
- Abstract 2214: COUP-TFII suppresses NFκB activation in endocrine-resistant breast cancer cells (2012) (0)
- m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. (2022) (0)
- GGNBP2 to suppress tumor growth through modulating ERα action in breast cancer. (2016) (0)
- The endocrine disruptors cadmium chloride and sodium arsenate activate estrogen receptor‐mediated signaling and induce human lung adenocarcinoma cell proliferation (2011) (0)
- Disruption of the Mouse Liver Epitranscriptome by Long-term Aroclor 1260 Exposure. (2023) (0)
- Abstract 2845: The role of PSAT1 in triple negative breast cancer metastasis (2019) (0)
- Abstract P1-01-15: Investigation of phosphoserine aminotransferase 1 and its role in breast cancer progression (2018) (0)
- The Role of Arylamine N‐acetyltransferase 1 in Breast Cancer Progression (2013) (0)
- An Innovative Approach for Curcumin Delivery for Breast Cancer Using Albumin Nanoparticles (2013) (0)
- Abstract 1402: HNRNPA2B1 increases the serine synthesis pathway in endocrine-resistant breast cancer cells (2021) (0)
- The endocrine disruptors cadmium chloride and sodium arsenate induce human lung adenocarcinoma cell proliferation by activating the estrogen receptor‐mediated signaling pathway (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Carolyn M. Klinge?
Carolyn M. Klinge is affiliated with the following schools:
